SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3186Longs in HCV related stocks shocked by GILD on average discount. No idea wheresemi_infinite -2/4/2015
3185ACHN -19% on a morning of widespread sellingtnsaf-2/4/2015
3184OTIC -19% at low; closed -14%, around the price of the new offering, which was atnsaf-1/23/2015
3183KITE again (15%, now 10% and heading north), post-JPM Healthcare. (blue, blcm, scaram(o)uche-1/20/2015
3182KITE -17%, possibly due to Reuters piece with surprising talk about pricing: silDewDiligence_on_SI-1/15/2015
3181Add SRNE to the list; off %27 at low, closed off 14% on 7 x 3-month averagetnsaf-1/15/2015
3180KITE, and it looks like JUNO might have made it as well (now off 13%, and it'scaram(o)uche-1/15/2015
3179It could be a death knell for the HBV program. Surprised ARWR isn't down morDewDiligence_on_SI-1/12/2015
3178Arrowhead Research (ARWR), which had been strong lately, off 24% on partial clintuck-1/12/2015
3177I wondered about those buying stock on news of release. Ouch!! Stock back to ThRobohogs-1/8/2015
3176CNAT -35% AH on data release from 3 trials; comments in siliconinvestor.com and DewDiligence_on_SI-1/8/2015
3175MDXG -15% currently; -21% at day's low so far on 6 x ADV Shares of MiMedx Gtnsaf-1/2/2015
3174ACHN -20%. The market giveth; the market taketh away. thestreet.comtnsaf-12/23/2014
3173IMGN 50% on Roche's Kadcyla trial failure.nigel bates-12/19/2014
3172Bind down over 15%. Only news is BIND-014 NSCLC results presented at EORTC. Hepgo-neil-11/19/2014
3171Milt..... Thanks for your SNO pointer (and to Tuck for his intro to the discscaram(o)uche-11/14/2014
3170AGIO -15% at low, closed -13% on 3 x ADV. Apparently some investors were not imptnsaf-11/8/2014
3169Yes, I've got a chunk of it. Bought in way back when the CRs were first desscaram(o)uche-11/6/2014
3168Interesting, thanks. Do you also follow Epizyme (EZYM)? It's down 22% thistuck-11/6/2014
3167These sort of beg the question... why caution? :-) Just catching up to the stscaram(o)uche-11/5/2014
3166This is clearly bad news on one of their more important programs. But it is jusbiofisher-11/5/2014
3165Phase III launched on back of data from a trial with four (4!) control patients scaram(o)uche-11/5/2014
3164Celldex (CLDX) off 17% on poor enrollment in its breast cancer trial. Company ituck-11/5/2014
3163ACHN -16% on apparent delay in reporting ACH-3422 monotherapy data: siliconinvesDewDiligence_on_SI-11/4/2014
3162I've always taken a yearly flu shot. But this study seems to suggest I shoulThe Dodgy Ticker-10/27/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News